METHOD OF MAKING THE NEW L-ASPARAGINANE OF THE CYCLIC ERYTHROMYCIN-A-CARBONATE
1443097 L-Aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate INSTYTUT PRZEMYSLU FARMACEUTYCZNEGO 22 July 1974 [28 July 1973] 32396/74 Heading C2C The novel antibiotic, the L-aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate is obtained, optionally as the monohydrate, by reacting s...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DAHLIG,HALINA,PL SZYPKA,ZDZISLAW,PL |
| description | 1443097 L-Aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate INSTYTUT PRZEMYSLU FARMACEUTYCZNEGO 22 July 1974 [28 July 1973] 32396/74 Heading C2C The novel antibiotic, the L-aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate is obtained, optionally as the monohydrate, by reacting substantially stoichiometric proportions of the cyclic carbonate of erythromycin A 6,9-hemiacetal and L-aspartic acid in an aqueous medium (e.g. H 2 O, H 2 O/acetone, H 2 O/ethanol). To isolate the product, the resulting solution may be lyophilized or evaporated with, if necessary, addition of a liquid which forms a binary or ternary azeotropic mixture therewith. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CS186272B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CS186272B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CS186272B23</originalsourceid><addsrcrecordid>eNrjZPDzdQ3x8HdR8HdT8HX09vRzVwjxcFXwcw1X8NF1DA5wDHJ09_Rz9HMFKQDJOEc6-3g6K7gGRYZ4BPn7Rjp7-uk66jo7Bjn5-zmGuPIwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknjnYEMLMyNzIycjY8IqACiMLVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD OF MAKING THE NEW L-ASPARAGINANE OF THE CYCLIC ERYTHROMYCIN-A-CARBONATE</title><source>esp@cenet</source><creator>DAHLIG,HALINA,PL ; SZYPKA,ZDZISLAW,PL</creator><creatorcontrib>DAHLIG,HALINA,PL ; SZYPKA,ZDZISLAW,PL</creatorcontrib><description>1443097 L-Aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate INSTYTUT PRZEMYSLU FARMACEUTYCZNEGO 22 July 1974 [28 July 1973] 32396/74 Heading C2C The novel antibiotic, the L-aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate is obtained, optionally as the monohydrate, by reacting substantially stoichiometric proportions of the cyclic carbonate of erythromycin A 6,9-hemiacetal and L-aspartic acid in an aqueous medium (e.g. H 2 O, H 2 O/acetone, H 2 O/ethanol). To isolate the product, the resulting solution may be lyophilized or evaporated with, if necessary, addition of a liquid which forms a binary or ternary azeotropic mixture therewith.</description><edition>2</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>1978</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19781130&DB=EPODOC&CC=CS&NR=186272B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19781130&DB=EPODOC&CC=CS&NR=186272B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAHLIG,HALINA,PL</creatorcontrib><creatorcontrib>SZYPKA,ZDZISLAW,PL</creatorcontrib><title>METHOD OF MAKING THE NEW L-ASPARAGINANE OF THE CYCLIC ERYTHROMYCIN-A-CARBONATE</title><description>1443097 L-Aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate INSTYTUT PRZEMYSLU FARMACEUTYCZNEGO 22 July 1974 [28 July 1973] 32396/74 Heading C2C The novel antibiotic, the L-aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate is obtained, optionally as the monohydrate, by reacting substantially stoichiometric proportions of the cyclic carbonate of erythromycin A 6,9-hemiacetal and L-aspartic acid in an aqueous medium (e.g. H 2 O, H 2 O/acetone, H 2 O/ethanol). To isolate the product, the resulting solution may be lyophilized or evaporated with, if necessary, addition of a liquid which forms a binary or ternary azeotropic mixture therewith.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1978</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPDzdQ3x8HdR8HdT8HX09vRzVwjxcFXwcw1X8NF1DA5wDHJ09_Rz9HMFKQDJOEc6-3g6K7gGRYZ4BPn7Rjp7-uk66jo7Bjn5-zmGuPIwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknjnYEMLMyNzIycjY8IqACiMLVQ</recordid><startdate>19781130</startdate><enddate>19781130</enddate><creator>DAHLIG,HALINA,PL</creator><creator>SZYPKA,ZDZISLAW,PL</creator><scope>EVB</scope></search><sort><creationdate>19781130</creationdate><title>METHOD OF MAKING THE NEW L-ASPARAGINANE OF THE CYCLIC ERYTHROMYCIN-A-CARBONATE</title><author>DAHLIG,HALINA,PL ; SZYPKA,ZDZISLAW,PL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CS186272B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1978</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>DAHLIG,HALINA,PL</creatorcontrib><creatorcontrib>SZYPKA,ZDZISLAW,PL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAHLIG,HALINA,PL</au><au>SZYPKA,ZDZISLAW,PL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD OF MAKING THE NEW L-ASPARAGINANE OF THE CYCLIC ERYTHROMYCIN-A-CARBONATE</title><date>1978-11-30</date><risdate>1978</risdate><abstract>1443097 L-Aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate INSTYTUT PRZEMYSLU FARMACEUTYCZNEGO 22 July 1974 [28 July 1973] 32396/74 Heading C2C The novel antibiotic, the L-aspartate of cyclic erythromycin A 6,9-hemiacetal carbonate is obtained, optionally as the monohydrate, by reacting substantially stoichiometric proportions of the cyclic carbonate of erythromycin A 6,9-hemiacetal and L-aspartic acid in an aqueous medium (e.g. H 2 O, H 2 O/acetone, H 2 O/ethanol). To isolate the product, the resulting solution may be lyophilized or evaporated with, if necessary, addition of a liquid which forms a binary or ternary azeotropic mixture therewith.</abstract><edition>2</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_CS186272B2 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | METHOD OF MAKING THE NEW L-ASPARAGINANE OF THE CYCLIC ERYTHROMYCIN-A-CARBONATE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A42%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAHLIG,HALINA,PL&rft.date=1978-11-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECS186272B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |